Mettler-Toledo International Inc. (MTD) DCF Valuation
Transparent DCF models put Mettler-Toledo International Inc. (MTD)'s fair value in a range of $562.86 – $665.58 — the low end is TGM's conservative base case (5% FCF growth, 10% discount), the high end the analyst consensus (FMP). Today's price of $1,162.79 sits above that range — by these conservative assumptions it looks richly valued; the reverse-DCF below is the better lens for a high-growth name.
Reverse DCF: at today's $1,162.79, the market is pricing in roughly +13.7%/yr free-cash-flow growth over the next decade (at a 10% required return) — versus its actual 5-year FCF CAGR of +2.0%. The price is betting on acceleration above its track record.
Current Price
$1,162.79
Fair-Value Range
$562.86 – $665.58
Market-Implied Growth
+13.7%/yr
vs +2.0% 5Y actual
MTD DCF Fair Value Calculator
Edit the assumptions to see how they change the estimated fair value. Illustrative model — not investment advice. Defaults to a conservative base case; the analyst (FMP) DCF, where available, is shown as a reference below.
Base inputs: FCF $827.9M · 0.02B shares · net debt $2.2B
Estimated Fair Value
$562.86
-51.6% vs $1162.79
Sensitivity — fair value by discount rate × terminal growth
How the estimated fair value shifts with the discount rate (WACC) and terminal growth, holding your 5.0%/yr FCF growth and 10-year horizon fixed. Green = above today's $1162.79; red = below. Your current case is outlined.
| WACC ↓ / Terminal → | 1.50% | 2.00% | 2.50% | 3.00% | 3.50% |
|---|---|---|---|---|---|
| 8.0% | $726 | $769 | $819 | $880 | $954 |
| 9.0% | $608 | $637 | $671 | $711 | $757 |
| 10.0% | $518 | $539 | $563 | $590 | $621 |
| 11.0% | $448 | $463 | $480 | $499 | $521 |
| 12.0% | $391 | $403 | $415 | $429 | $445 |
About Mettler-Toledo International Inc.
Mettler-Toledo International Inc. (MTD) is a global enterprise dedicated to the production and provision of precision instruments and related services. The company's operations are strategically organized across five geographical divisions: its domestic U.S. market, Swiss operations, Western European activities, Chinese operations, and an 'Other' segment covering remaining territories. Their extensive product portfolio serves diverse scientific and industrial needs. Within the laboratory sphere, Mettler-Toledo supplies a comprehensive array of equipment, including high-precision balances, advanced liquid handling systems (such as pipetting solutions), automated laboratory reactors, titrators, pH meters, sensors and analyzers for process analytics, instruments for evaluating physical properties, thermal analysis systems, and various other analytical tools. These hardware offerings are complemented by LabX, their proprietary software platform designed for managing and analyzing instrument-generated data. For industrial applications, the company offers robust weighing instruments with associated terminals, automated systems for dimensional measurement and data capture, heavy-duty vehicle scales, specialized industrial software, and a full suite of product inspection technologies. This includes metal detectors, X-ray inspection systems, checkweighers, camera-based imaging equipment, and solutions for track-and-trace. Additionally, Mettler-Toledo provides sophisticated retail weighing solutions, encompassing networked scales and accompanying software, standalone scales, and automated packaging and labeling systems specifically tailored for fresh food items. The company caters to a wide spectrum of clients, including the life sciences sector, independent research organizations, testing laboratories, food and beverage manufacturers, food retailers, chemical, specialty chemical, and cosmetics companies, transportation and logistics firms, metals and electronics industries, and the academic community. Sales and support are conducted through both a direct sales force and an established network of indirect distribution channels. Mettler-Toledo International Inc. was founded in 1991 and is headquartered in Columbus, Ohio.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Patrick K. Kaltenbach